McNeil-Goldman Scleral and Blepharostat Ring - Pediatric
Navigation Links
McNeil-Goldman Scleral and Blepharostat Ring - Pediatric
| Products | McNeil-Goldman Scleral and Blepharostat Ring - Pediatric |
| Company | Bausch & Lomb Storz |
| Item | McNeil-Goldman Scleral and Blepharostat Ring - Pediatric |
| Features | |
| Description | Pediatric size. Loops retract lids. Polished finish. |
| Info | Bausch & Lomb Storz Customer Service: (585) 338-6000 Web site: http://www.storz.com/ |
Related medicine products :
1. McNeil-Goldman Scleral and Blepharostat Ring
2. Scleral Plugs
3. Scleral Blade tip 5700 style, straight
4. Catalano Corneal Scleral Forceps - 0.12 mm
5. Catalano Corneal Scleral Forceps
6. Scleral Plug Forceps
7. Scleral blades
8. Scleral knives
9. BD Pocket Scleral Blades and Knives
10. Gass Scleral Marker, Thimble Style
11. Cook Eye Speculum - Pediatric
Breaking Medicine News(10 mins):Health News:Traceability Institute Comments on Improving Food Safety System for Consumers at Food and Drug Administration (FDA) and Food Safety and Inspection Service (FSIS) Joint Public Meeting 2Health News:Weight Watchers Declares Quarterly Dividend 2Health News:Most Hospital Patients Don't Know What Meds They're Taking 2Health News:Most Hospital Patients Don't Know What Meds They're Taking 3Health News:NBTY to be Featured on the FOX Business Program FOXBusiness.com LIVE 2Health News:Depression Survey: Implications for Diverse Communities 2
[1] Traceability Institute Comments on Improving Food Safety System for Consumers at Food and Drug Administration (FDA) and Food Safety and Inspection Service (FSIS) Joint Public Meeting[0] Weight Watchers Declares Quarterly Dividend[0] Most Hospital Patients Don't Know What Meds They're Taking[0] NBTY to be Featured on the FOX Business Program FOXBusiness.com LIVE[0] Depression Survey: Implications for Diverse Communities
Other Medicine News:Health News:Global Med Technologies(R), Inc. Implements Transfusion Management System in Large Private Physician Owned Laboratory 2Health News:Global Med Technologies(R), Inc. Implements Transfusion Management System in Large Private Physician Owned Laboratory 3Health News:Global Med Technologies(R), Inc. Implements Transfusion Management System in Large Private Physician Owned Laboratory 4Health News:Blue Cross and Blue Shield of Georgia Expands Breast Cancer Care Program 2Health News:Blue Cross and Blue Shield of Georgia Expands Breast Cancer Care Program 3Health News:Perrigo Company Licenses Prescription Brands to Medimetriks Pharmaceuticals 2Health News:Biopure Receives Extension of Time to Regain NASDAQ Listing Compliance 2Health News:Informed-Choice Reinforces Need to Test Supplements for Inadvertent Contamination After Recent NFL Players' Positive Tests 2Health News:Pharmasset to Webcast an Investor Event from the AASLD Meeting 2Health News:Pharmasset to Webcast an Investor Event from the AASLD Meeting 3
Global Med Technologies(R), Inc. Implements Transfusion Management System in Large Private Physician Owned LaboratoryBlue Cross and Blue Shield of Georgia Expands Breast Cancer Care ProgramPerrigo Company Licenses Prescription Brands to Medimetriks PharmaceuticalsBiopure Receives Extension of Time to Regain NASDAQ Listing ComplianceInformed-Choice Reinforces Need to Test Supplements for Inadvertent Contamination After Recent NFL Players' Positive TestsPharmasset to Webcast an Investor Event from the AASLD Meeting
Breaking Medicine Technology:China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 4Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 5Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 6Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 7Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 8Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 9Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 11Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 12Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 13Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 14Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 15Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 16Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 17Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 18UNC awarded 246 2 million renewal grant by NIH Rare Diseases Research Network 10336 1UNC awarded 246 2 million renewal grant by NIH Rare Diseases Research Network 10336 2 Tired Doctors More Prone to Errors 59371 1 Tired Doctors More Prone to Errors 59371 2 Tired Doctors More Prone to Errors 59371 3Discover Red Mangos New Seasonal Flavor 3A Pumpkin Spice 59366 1Discover Red Mangos New Seasonal Flavor 3A Pumpkin Spice 59366 2
[0] China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009[0] New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies[0] Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |